Alternaria alternata TCTP, a novel cross-reactive ascomycete allergen

Molecular Immunology

Volumn 46, Issue 16, 2009, Pages 3476-3487

  Rid, Raphaela ^a   Önder, Kamil ^a,b   MacDonald, Susan ^c   Lang, Roland ^b   Hawranek, Thomas ^b   Ebner, Christof ^d   Hemmer, Wolfgang ^e   Richter, Klaus ^a   Simon Nobbe, Birgit ^a   Breitenbach, Michael ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b Department of Dermatology   (Austria)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^d Allergie Ambulatorium Reumannplatz   (Austria)

^e FAZ Floridsdorfer Allergiezentrum   (Austria)

Author keywords

Allergy; Alternaria alternata; Ascomycete; Fungi; Mold; Recombinant protein; TCTP

Indexed keywords

ALLERGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN E; RECOMBINANT TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; UNCLASSIFIED DRUG;

ALTERNARIA ALTERNATA; AMINO ACID SEQUENCE; ARTICLE; CIRCULAR DICHROISM; CLADOSPORIUM; CLADOSPORIUM HERBARUM; CONTROLLED STUDY; CROSS REACTION; IMMUNOREACTIVITY; IN VITRO STUDY; INHIBITION KINETICS; ISOTOPE LABELING; MOLECULAR CLONING; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; WESTERN BLOTTING;

ALLERGENS; ALTERNARIA; ANIMALS; ANTIGENS, FUNGAL; BASE SEQUENCE; CLADOSPORIUM; CLONING, MOLECULAR; FUNGAL PROTEINS; HUMANS; IMMUNOGLOBULIN E; MOLECULAR SEQUENCE DATA; RHINITIS, ALLERGIC, SEASONAL;

ALTERNARIA ALTERNATA; DAVIDIELLA TASSIANA; FUNGI; PROTISTA;

EID: 70349445290     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.07.024     Document Type: Article

References (95)

1. Aalberse R.C., Akkerdaas J., and van Ree R. Cross-reactivity of IgE antibodies to allergens. Allergy 56 (2001) 478-490
2. Achatz G., Oberkofler H., Lechenauer E., Simon B., Unger A., Kandler D., Ebner C., Prillinger H., Kraft D., and Breitenbach M. Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol. Immunol. 32 (1995) 213-227
3. Achatz G., Oberkofler H., Lechenauer E., Simon B., Unger A., Kandler D., Ebner C., Prillinger H., Kraft D., and Breitenbach M. Molecular characterization of Alternaria alternata and Cladosporium herbarum allergens. Adv. Exp. Med. Biol. 409 (1996) 157-161
4. Al-Samarrai T.H., and Schmid J. A simple method for extraction of fungal genomic DNA. Lett. Appl. Microbiol. 30 (2000) 53-56
5. Amzallag N., Passer B.J., Allanic D., Segura E., Thery C., Goud B., Amson R., and Telerman A. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J. Biol. Chem. 279 (2004) 46104-46112
6. Appenzeller U., Meyer C., Menz G., Blaser K., and Crameri R. IgE-mediated reactions to autoantigens in allergic diseases. Int. Arch. Allergy Immunol. 118 (1999) 193-196
7. Bairoch A., Apweiler R., Wu C.H., Barker W.C., Boeckmann B., Ferro S., Gasteiger E., Huang H., Lopez R., Magrane M., Martin M.J., Natale D.A., O'Donovan C., Redaschi N., and Yeh L.S. The Universal Protein Resource (UniProt). Nucleic Acids Res. 33 (2005) D154-D159
8. Baxter N.J., Thaw P., Higgins L.D., Sedelnikova S.E., Bramley A.L., Price C., Waltho J.P., and Craven C.J. Backbone NMR assignment of the 19 kDa translationally controlled tumor-associated protein p23fyp from Schizosaccharomyces pombe. J. Biomol. NMR 16 (2000) 83-84
9. Bheekha-Escura R., Chance S.R., Langdon J.M., MacGlashan Jr. D.W., and MacDonald S.M. Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor. J. Allergy Clin. Immunol. 103 (1999) 937-943
10. Bheekha-Escura R., MacGlashan D.W., Langdon J.M., and MacDonald S.M. Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line AML14-3D10. Blood 96 (2000) 2191-2198
11. Bhisutthibhan J., Pan X.Q., Hossler P.A., Walker D.J., Yowell C.A., Carlton J., Dame J.B., and Meshnick S.R. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J. Biol. Chem. 273 (1998) 16192-16198
12. Black P.N., Udy A.A., and Brodie S.M. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 55 (2000) 501-504
13. Bommer U.A., and Thiele B.J. The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 36 (2004) 379-385
14. Bonifazi F. Immunotherapy in pollen and mould asthma. Monaldi Arch. Chest Dis. 49 (1994) 150-153
15. Bonnet C., Perret E., Dumont X., Picard A., Caput D., and Lenaers G. Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest. Yeast 16 (2000) 23-33
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
17. Breitenbach M., and Simon-Nobbe B. The allergens of Cladosporium herbarum and Alternaria alternata. Chem. Immunol. 81 (2002) 48-72
18. Burge H.A. An update on pollen and fungal spore aerobiology. J. Allergy Clin. Immunol. 110 (2002) 544-552
19. Bush R.K., Portnoy J.M., Saxon A., Terr A.I., and Wood R.A. The medical effects of mold exposure. J. Allergy Clin. Immunol. 117 (2006) 326-333
20. Bush R.K., and Prochnau J.J. Alternaria-induced asthma. J. Allergy Clin. Immunol. 113 (2004) 227-234
21. Cans C., Passer B.J., Shalak V., Nancy-Portebois V., Crible V., Amzallag N., Allanic D., Tufino R., Argentini M., Moras D., Fiucci G., Goud B., Mirande M., Amson R., and Telerman A. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13892-13897
22. Crameri R., Faith A., Hemmann S., Jaussi R., Ismail C., Menz G., and Blaser K. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J. Exp. Med. 184 (1996) 265-270
23. Crameri R., Weichel M., Fluckiger S., Glaser A.G., and Rhyner C. Fungal allergies: a yet unsolved problem. Chem. Immunol. Allergy 91 (2006) 121-133
24. Cromwell O., Suck R., Kahlert H., Nandy A., Weber B., and Fiebig H. Transition of recombinant allergens from bench to clinical application. Methods 32 (2004) 300-312
25. De Vouge M.W., Thaker A.J., Zhang L., Muradia G., Rode H., and Vijay H.M. Molecular cloning of IgE-binding fragments of Alternaria alternata allergens. Int. Arch. Allergy Immunol. 116 (1998) 261-268
26. Delfino R.J., Coate B.D., Zeiger R.S., Seltzer J.M., Street D.H., and Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am. J. Respir. Crit. Care Med. 154 (1996) 633-641
27. Downs S.H., Mitakakis T.Z., Marks G.B., Car N.G., Belousova E.G., Leuppi J.D., Xuan W., Downie S.R., Tobias A., and Peat J.K. Clinical importance of Alternaria exposure in children. Am. J. Respir. Crit. Care Med. 164 (2001) 455-459
28. Eggleston P.A. The environment and asthma in US inner cities. Chest 132 (2007) 782S-788S
29. Esch R.E. Manufacturing and standardizing fungal allergen products. J. Allergy Clin. Immunol. 113 (2004) 210-215
30. Feng Y., Liu D., Yao H., and Wang J. Solution structure and mapping of a very weak calcium-binding site of human translationally controlled tumor protein by NMR. Arch. Biochem. Biophys. 467 (2007) 48-57
31. Ferreira F., Wallner M., and Thalhamer J. Customized antigens for desensitizing allergic patients. Adv. Immunol. 84 (2004) 79-129
32. Fluckiger S., Scapozza L., Mayer C., Blaser K., Folkers G., and Crameri R. Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int. Arch. Allergy Immunol. 128 (2002) 292-303
33. Frew A.J. Mold allergy: some progress made, more needed. J. Allergy Clin. Immunol. 113 (2004) 216-218
34. Fujita T., Felix K., Pinkaew D., Hutadilok-Towatana N., Liu Z., and Fujise K. Human fortilin is a molecular target of dihydroartemisinin. FEBS Lett. 582 (2008) 1055-1060
35. Gachet Y., Tournier S., Lee M., Lazaris-Karatzas A., Poulton T., and Bommer U.A. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell Sci. 112 Pt 8 (1999) 1257-1271
36. Gasteiger E., Jung E., and Bairoch A. SWISS-PROT: connecting biomolecular knowledge via a protein database. Curr. Issues Mol. Biol. 3 (2001) 47-55
37. Gergen P.J., Turkeltaub P.C., and Kovar M.G. The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey. J. Allergy Clin. Immunol. 80 (1987) 669-679
38. Gnanasekar M., Rao K.V., Chen L., Narayanan R.B., Geetha M., Scott A.L., Ramaswamy K., and Kaliraj P. Molecular characterization of a calcium binding translationally controlled tumor protein homologue from the filarial parasites Brugia malayi and Wuchereria bancrofti. Mol. Biochem. Parasitol. 121 (2002) 107-118
39. 2+-dependent apoptosis in vivo. Biochem. J. 408 (2007) 181-191
40. Hinojosa-Moya J., Xoconostle-Cazares B., Piedra-Ibarra E., Mendez-Tenorio A., Lucas W.J., and Ruiz-Medrano R. Phylogenetic and structural analysis of translationally controlled tumor proteins. J. Mol. Evol. 66 (2008) 472-483
41. Horner W.E., Helbling A., Salvaggio J.E., and Lehrer S.B. Fungal allergens. Clin. Microbiol. Rev. 8 (1995) 161-179
42. Hsu Y.C., Chern J.J., Cai Y., Liu M., and Choi K.W. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445 (2007) 785-788
43. Jacob B., Ritz B., Gehring U., Koch A., Bischof W., Wichmann H.E., and Heinrich J. Indoor exposure to molds and allergic sensitization. Environ. Health Perspect. 110 (2002) 647-653
44. Kang H.S., Lee M.J., Song H., Han S.H., Kim Y.M., Im J.Y., and Choi I. Molecular identification of IgE-dependent histamine-releasing factor as a B cell growth factor. J. Immunol. 166 (2001) 6545-6554
45. Kapust R.B., Tozser J., Fox J.D., Anderson D.E., Cherry S., Copeland T.D., and Waugh D.S. Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng. 14 (2001) 993-1000
46. Karihaloo C., Tovey E.R., Mitakakis T.Z., Duffy D.L., and Britton W.J. Evidence for the genetic control of immunoglobulin E reactivity to the allergens of Alternaria alternata. Clin. Exp. Allergy 32 (2002) 1316-1322
47. Kurup V.P., and Banerjee B. Fungal allergens and peptide epitopes. Peptides 21 (2000) 589-599
48. Kurup V.P., Shen H.D., and Banerjee B. Respiratory fungal allergy. Microbes Infect. 2 (2000) 1101-1110
49. Kurup V.P., Shen H.D., and Vijay H. Immunobiology of fungal allergens. Int. Arch. Allergy Immunol. 129 (2002) 181-188
50. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
51. Langdon J.M., Vonakis B.M., and MacDonald S.M. Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta). Biochim. Biophys. Acta 1688 (2004) 232-236
52. Larsen J.E., Lund O., and Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2 (2006) 2
53. Lee J.H., Rho S.B., Park S.Y., and Chun T. Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22. FEBS Lett. 582 (2008) 1210-1218
54. Liu H., Peng H.W., Cheng Y.S., Yuan H.S., and Yang-Yen H.F. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol. Cell. Biol. 25 (2005) 3117-3126
55. Lizaso M.T., Tabar A.I., Garcia B.E., Gomez B., Algorta J., Asturias J.A., and Martinez A. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters. Pediatr. Allergy Immunol. 19 (2008) 76-81
56. MacDonald S.M. Human recombinant histamine-releasing factor. Int. Arch. Allergy Immunol. 113 (1997) 187-189
57. MacDonald S.M., Bhisutthibhan J., Shapiro T.A., Rogerson S.J., Taylor T.E., Tembo M., Langdon J.M., and Meshnick S.R. Immune mimicry in malaria: plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10829-10832
58. MacDonald S.M., Rafnar T., Langdon J., and Lichtenstein L.M. Molecular identification of an IgE-dependent histamine-releasing factor. Science 269 (1995) 688-690
59. MacDonald S.M., and Vonakis B.M. Association of the Src homology 2 domain-containing inositol 5′ phosphatase (SHIP) to releasability in human basophils. Mol. Immunol. 38 (2002) 1323-1327
60. Mak C.H., Poon M.W., Lun H.M., Kwok P.Y., and Ko R.C. Heat-inducible translationally controlled tumor protein of Trichinella pseudospiralis: cloning and regulation of gene expression. Parasitol. Res. 100 (2007) 1105-1111
61. Malling H.J. Immunotherapy for mold allergy. Clin. Rev. Allergy 10 (1992) 237-251
62. Mayer C., Appenzeller U., Seelbach H., Achatz G., Oberkofler H., Breitenbach M., Blaser K., and Crameri R. Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J. Exp. Med. 189 (1999) 1507-1512
63. Neukirch C., Henry C., Leynaert B., Liard R., Bousquet J., and Neukirch F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J. Allergy Clin. Immunol. 103 (1999) 709-711
64. Niederberger V., and Valenta R. Genetically modified allergens. Immunol. Allergy Clin. N. Am. 24 (2004) 727-738
65. Oikawa K., Ohbayashi T., Mimura J., Fujii-Kuriyama Y., Teshima S., Rokutan K., Mukai K., and Kuroda M. Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem. Biophys. Res. Commun. 290 (2002) 984-987
66. Portnoy J.M., Barnes C.S., and Kennedy K. Sampling for indoor fungi. J. Allergy Clin. Immunol. 113 (2004) 199 189-98; quiz
67. Rao K.V., Chen L., Gnanasekar M., and Ramaswamy K. Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J. Biol. Chem. 277 (2002) 31207-31213
68. Rid R., Simon-Nobbe B., Langdon J., Holler C., Wally V., Poll V., Ebner C., Hemmer W., Hawranek T., Lang R., Richter K., MacDonald S., Rinnerthaler M., Laun P., Mari A., and Breitenbach M. Cladosporium herbarum translationally controlled tumor protein (TCTP) is an IgE-binding antigen and is associated with disease severity. Mol. Immunol. 45 (2008) 406-418
69. Rottem M., and Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int. Arch. Allergy Immunol. 132 (2003) 210-214
70. Salo P.M., Arbes Jr. S.J., Sever M., Jaramillo R., Cohn R.D., London S.J., and Zeldin D.C. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J. Allergy Clin. Immunol. 118 (2006) 892-898
71. Sanchez H., and Bush R.K. A review of Alternaria alternata sensitivity. Rev. Iberoam. Micol. 18 (2001) 56-59
72. Sanchez J.C., Schaller D., Ravier F., Golaz O., Jaccoud S., Belet M., Wilkins M.R., James R., Deshusses J., and Hochstrasser D. Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis 18 (1997) 150-155
73. Schmid-Grendelmeier P., Fluckiger S., Disch R., Trautmann A., Wuthrich B., Blaser K., Scheynius A., and Crameri R. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J. Allergy Clin. Immunol. 115 (2005) 1068-1075
74. Schneider P.B., Denk U., Breitenbach M., Richter K., Schmid-Grendelmeier P., Nobbe S., Himly M., Mari A., Ebner C., and Simon-Nobbe B. Alternaria alternata NADP-dependent mannitol dehydrogenase is an important fungal allergen. Clin. Exp. Allergy 36 (2006) 1513-1524
75. Schroeder J.T., Lichtenstein L.M., and MacDonald S.M. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J. Immunol. 159 (1997) 447-452
76. Shankar J., Singh B.P., Gaur S.N., and Arora N. Recombinant glutathione-S-transferase a major allergen from Alternaria alternata for clinical use in allergy patients. Mol. Immunol. 43 (2006) 1927-1932
77. Sheffield P., Garrard S., and Derewenda Z. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expres. Purif. 15 (1999) 34-39
78. Simon-Nobbe B., Denk U., Poll V., Rid R., and Breitenbach M. The spectrum of fungal allergy. Int. Arch. Allergy Immunol. 145 (2008) 58-86
79. Simon-Nobbe B., Probst G., Kajava A.V., Oberkofler H., Susani M., Crameri R., Ferreira F., Ebner C., and Breitenbach M. IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J. Allergy Clin. Immunol. 106 (2000) 887-895
80. Susini L., Besse S., Duflaut D., Lespagnol A., Beekman C., Fiucci G., Atkinson A.R., Busso D., Poussin P., Marine J.C., Martinou J.C., Cavarelli J., Moras D., Amson R., and Telerman A. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 15 (2008) 1211-1220
81. Tabar A.I., Lizaso M.T., Garcia B.E., Gomez B., Echechipia S., Aldunate M.T., Madariaga B., and Martinez A. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr. Allergy Immunol. 19 (2008) 67-75
82. Terr A.I. Are indoor molds causing a new disease?. J. Allergy Clin. Immunol. 113 (2004) 221-226
83. Thapa A., Shahnawaz M., Karki P., Raj Dahal G., Golam Sharoar M., Yub Shin S., Sup Lee J., Cho B., and Park I.S. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins. Biotechniques 44 (2008) 787-796
84. Thaw P., Baxter N.J., Hounslow A.M., Price C., Waltho J.P., and Craven C.J. Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones. Nat. Struct. Biol. 8 (2001) 701-704
85. Tuynder M., Fiucci G., Prieur S., Lespagnol A., Geant A., Beaucourt S., Duflaut D., Besse S., Susini L., Cavarelli J., Moras D., Amson R., and Telerman A. Translationally controlled tumor protein is a target of tumor reversion. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15364-15369
86. Unger A., Stoger P., Simon-Nobbe B., Susani M., Crameri R., Ebner C., Hintner H., and Breitenbach M. Clinical testing of recombinant allergens of the mold Alternaria alternata. Int. Arch. Allergy Immunol. 118 (1999) 220-221
87. Vailes L., Sridhara S., Cromwell O., Weber B., Breitenbach M., and Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J. Allergy Clin. Immunol. 107 (2001) 641-646
88. Valenta R. Recombinant allergen-based concepts for diagnosis and therapy of type I allergy. Allergy 57 Suppl 71 (2002) 66-67
89. Valenta R., and Niederberger V. Recombinant allergens for immunotherapy. J. Allergy Clin. Immunol. 119 (2007) 826-830
90. Venugopal T. Evolution and expression of translationally controlled tumour protein (TCTP) of fish. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 142 (2005) 8-17
91. Weichel M., Schmid-Grendelmeier P., Fluckiger S., Breitenbach M., Blaser K., and Crameri R. Nuclear transport factor 2 represents a novel cross-reactive fungal allergen. Allergy 58 (2003) 198-206
92. Yan L., Fei K., Bridge D., and Sarras Jr. M.P. A cnidarian homologue of translationally controlled tumor protein (P23/TCTP). Dev. Genes Evol. 210 (2000) 507-511
93. Yang Y., Yang F., Xiong Z., Yan Y., Wang X., Nishino M., Mirkovic D., Nguyen J., Wang H., and Yang X.F. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 24 (2005) 4778-4788
94. Yarm F.R. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell. Biol. 22 (2002) 6209-6221
95. Zureik M., Neukirch C., Leynaert B., Liard R., Bousquet J., and Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 325 (2002) 411-414